Changchun Genescience Pharmaceutical Co., Ltd.

This study tests a new injectable form of leuprolide in 211 premenopausal women with hormone-positive breast cancer. The goal is to see if it can safely keep estrogen at postmenopausal levels for nearly a year, which helps control cancer growth. Participants receive the drug and …

This study checks if a new version of cabergoline tablets works the same as the standard version in 72 healthy Chinese adults aged 18-45. Participants take one dose of each version under fasting or after a meal, with blood tests to measure drug levels. The goal is to confirm bioe…

This early-stage study looks at how healthy postmenopausal women absorb, break down, and eliminate the drug GS1-144. Six participants will take a single oral dose, and researchers will measure the drug and its byproducts in blood, urine, and stool. The goal is to understand the d…